BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30824175)

  • 1. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice].
    de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A;
    Therapie; 2023; 78(6):691-703. PubMed ID: 36841652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
    Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):993-1000. PubMed ID: 32133717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives.
    de Germay S; Berdaï D; Noize P
    Therapie; 2022; 77(2):229-240. PubMed ID: 34973825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.
    Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice.
    de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A;
    Therapie; 2023; 78(6):679-689. PubMed ID: 36841656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Record linkage for pharmacoepidemiological studies in cancer patients.
    Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.
    Dupui M; Micallef J; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of pharmacoepidemiology of orphan drugs in rare diseases.
    Lapeyre-Mestre M
    Therapie; 2020 Apr; 75(2):215-220. PubMed ID: 32164974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives.
    Revet A; Moulis G; Raynaud JP; Bui E; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2022 Feb; 36(1):16-34. PubMed ID: 33998708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
    Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful linkage of French large-scale national registry populations to national reimbursement data: Improved data completeness and minimized loss to follow-up.
    Didier R; Gouysse M; Eltchaninoff H; Le Breton H; Commeau P; Cayla G; Glatt N; Glatt B; Gabbas M; Tuppin P; Liepchitz L; Boussac M; Iung B; Gilard M
    Arch Cardiovasc Dis; 2020; 113(8-9):534-541. PubMed ID: 32712203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.
    Sinnott SJ; Bennett K; Cahir C
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1449-1455. PubMed ID: 28819675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.
    Latry P; Molimard M; Bégaud B; Martin-Latry K
    Eur J Clin Pharmacol; 2010 Jul; 66(7):743-8. PubMed ID: 20429000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
    Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health.
    Davis KAS; Farooq S; Hayes JF; John A; Lee W; MacCabe JH; McIntosh A; Osborn DPJ; Stewart RJ; Woelbert E
    Lancet Psychiatry; 2020 Apr; 7(4):363-370. PubMed ID: 31780306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
    Larsen MD; Cars T; Hallas J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research.
    Ankrah D; Hallas J; Odei J; Asenso-Boadi F; Dsane-Selby L; Donneyong M
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):18-27. PubMed ID: 30260590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.